Cargando…

Gastrointestinal and metabolic function in the MPTP-treated macaque model of Parkinson's disease

BACKGROUND: Gastrointestinal (GI) and metabolic function are frequently altered in Parkinson's disease (PD). Although enteric nervous system anatomopathological alterations have previously been reported in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) monkey model of PD, the resulting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delamarre, Anna, MacSweeney, Cliona, Suzuki, Rie, Brown, Alastair JH., Li, Qin, Pioli, Elsa Y., Bezard, Erwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772551/ https://www.ncbi.nlm.nih.gov/pubmed/33385085 http://dx.doi.org/10.1016/j.heliyon.2020.e05771

Ejemplares similares

Decreased Rhes mRNA levels in the brain of patients with Parkinson’s disease and MPTP-treated macaques
por: Napolitano, Francesco, et al.
Publicado: (2017)

The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients
por: Nuzzo, Tommaso, et al.
Publicado: (2019)

Dopamine Transporter Binding Is Unaffected by L-DOPA Administration in Normal and MPTP-Treated Monkeys
por: Fernagut, Pierre-Olivier, et al.
Publicado: (2010)

Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson’s disease primate model
por: Kaya, Ibrahim, et al.
Publicado: (2023)

Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaques
por: Dehay, Benjamin, et al.
Publicado: (2012)

Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2015)

Microdialysis in awake macaque monkeys for central nervous system pharmacokinetics
por: Thiollier, Thibaud, et al.
Publicado: (2018)

Vector-mediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson’s disease
por: Rosenblad, Carl, et al.
Publicado: (2019)

Behavioural Profiles in Captive-Bred Cynomolgus Macaques: Towards Monkey Models of Mental Disorders?
por: Camus, Sandrine M. J., et al.
Publicado: (2013)

Social behavioral changes in MPTP-treated monkey model of Parkinson's disease
por: Durand, Elodie, et al.
Publicado: (2015)

MPTP-Treated Zebrafish Recapitulate ‘Late-Stage’ Parkinson’s-like Cognitive Decline
por: Bashirzade, Alim A. O., et al.
Publicado: (2022)

Depressive-like behavioral profiles in captive-bred single- and socially-housed rhesus and cynomolgus macaques: a species comparison
por: Camus, Sandrine M. J., et al.
Publicado: (2014)

Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism
por: Baufreton, Jérôme, et al.
Publicado: (2018)

Restoration of intestinal function in an MPTP model of Parkinson’s Disease
por: Ellett, L. J., et al.
Publicado: (2016)

Autotransphntation of the Cervical Sympathetic Ganglion into Monkeys With MPTP-Induced Parkinsonism
por: Itakura, Toru, et al.
Publicado: (1992)

Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection
por: Omar, Noor Azzizah, et al.
Publicado: (2023)

Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson’s disease treated with L-DOPA
por: Zhao, Ting Ting, et al.
Publicado: (2017)

PET Analysis of Dopaminergic Neurodegeneration in Relation to Immobility in the MPTP-Treated Common Marmoset, a Model for Parkinson’s Disease
por: Ando, Kiyoshi, et al.
Publicado: (2012)

RIPK1-Induced A1 Reactive Astrocytes in Brain in MPTP-Treated Murine Model of Parkinson’s Disease
por: Qiao, Chenmeng, et al.
Publicado: (2023)

The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease
por: Mustafa, S., et al.
Publicado: (2016)

Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson's disease
por: Bagga, Puneet, et al.
Publicado: (2016)

The Neuroprotective Effects of Cinnamic Aldehyde in an MPTP Mouse Model of Parkinson’s Disease
por: Bae, Woom-Yee, et al.
Publicado: (2018)

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease
por: Huang, Dongping, et al.
Publicado: (2017)

The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease
por: Schwenkgrub, Joanna, et al.
Publicado: (2017)

Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model
por: Liu, Yingjuan, et al.
Publicado: (2020)

Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives
por: Wianny, Florence, et al.
Publicado: (2017)

Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson's Disease
por: Ma, Yuanyuan, et al.
Publicado: (2022)

Characterization of retinal function and structure in the MPTP murine model of Parkinson’s disease
por: Tran, Katie K. N., et al.
Publicado: (2022)

GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP
por: Fazzari, Maria, et al.
Publicado: (2023)

Pilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques
por: Arotcarena, Marie-Laure, et al.
Publicado: (2021)

The MPTP Story
por: Langston, J. William
Publicado: (2017)

Similar neuronal imprint and no cross-seeded fibrils in α-synuclein aggregates from MSA and Parkinson’s disease
por: Laferrière, Florent, et al.
Publicado: (2022)

Angiogenin in Parkinson Disease Models: Role of Akt Phosphorylation and Evaluation of AAV-Mediated Angiogenin Expression in MPTP Treated Mice
por: Steidinger, Trent U., et al.
Publicado: (2013)

How Lazy Reading and Semantic Sloppiness May Harm Progress in Synucleinopathy Research
por: Bezard, Erwan
Publicado: (2022)

Olfaction in Three Genetic and Two MPTP-Induced Parkinson’s Disease Mouse Models
por: Kurtenbach, Stefan, et al.
Publicado: (2013)

Acylated but not des‐acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's disease
por: Bayliss, Jacqueline A., et al.
Publicado: (2016)

Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson’s Disease
por: Wang, Li-Yuan, et al.
Publicado: (2019)

Inflammatory Response Modulation by Vitamin C in an MPTP Mouse Model of Parkinson’s Disease
por: De Nuccio, Francesco, et al.
Publicado: (2021)

Anti-Inflammatory and Neuroprotective Effects of Morin in an MPTP-Induced Parkinson’s Disease Model
por: Hong, Dong Geun, et al.
Publicado: (2022)

Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease
por: Ma, Chunmei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v642v1bs8531tai468j3kh3ue8